Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
prnewswire.com
news
2022-10-20 10:45:00

Third quarter revenues of $2.49 billion, down 10.4% from 2021
Third quarter reported diluted earnings per share ("EPS") of $2.17, down 46.0% from 2021; and adjusted diluted EPS of $2.36, down 40.4% from 2021
Third quarter base business revenues of $2.17 billion, up 5.1% from 2021
Full year 2022 reported diluted EPS now expected to be between $8.52 and $8.72; and adjusted diluted EPS expected to be between $9.75 and $9.95

SECAUCUS, N.J., Oct. 20, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended SeptemberÂ 30, 2022.
